Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Automated preparation of clinical grade [68Ga]Ga-DOTA-CP04, a cholecystokinin-2 receptor agonist, using iPHASE MultiSyn synthesis platform.

Haskali MB, Roselt PD, Binns D, Hetsron A, Poniger S, Hutton CA, Hicks RJ.

EJNMMI Radiopharm Chem. 2019 Aug 23;4(1):23. doi: 10.1186/s41181-019-0067-2.

2.

Modification of Biodistribution and Brain Uptake of Copper Bis(thiosemicarbazonato) Complexes by the Incorporation of Amine and Polyamine Functional Groups.

Paterson BM, Cullinane C, Crouch PJ, White AR, Barnham KJ, Roselt PD, Noonan W, Binns D, Hicks RJ, Donnelly PS.

Inorg Chem. 2019 Apr 1;58(7):4540-4552. doi: 10.1021/acs.inorgchem.9b00117. Epub 2019 Mar 14.

PMID:
30869878
3.

Palmitoylation and Membrane Binding of Arc/Arg3.1: A Potential Role in Synaptic Depression.

Barylko B, Wilkerson JR, Cavalier SH, Binns DD, James NG, Jameson DM, Huber KM, Albanesi JP.

Biochemistry. 2018 Feb 6;57(5):520-524. doi: 10.1021/acs.biochem.7b00959. Epub 2017 Dec 26.

PMID:
29264923
4.

Cold Kit for Prostate-Specific Membrane Antigen (PSMA) PET Imaging: Phase 1 Study of 68Ga-Tris(Hydroxypyridinone)-PSMA PET/CT in Patients with Prostate Cancer.

Hofman MS, Eu P, Jackson P, Hong E, Binns D, Iravani A, Murphy D, Mitchell C, Siva S, Hicks RJ, Young JD, Blower PJ, Mullen GE.

J Nucl Med. 2018 Apr;59(4):625-631. doi: 10.2967/jnumed.117.199554. Epub 2017 Oct 6.

5.

Pet10p is a yeast perilipin that stabilizes lipid droplets and promotes their assembly.

Gao Q, Binns DD, Kinch LN, Grishin NV, Ortiz N, Chen X, Goodman JM.

J Cell Biol. 2017 Oct 2;216(10):3199-3217. doi: 10.1083/jcb.201610013. Epub 2017 Aug 11.

6.

EORTC PET response criteria are more influenced by reconstruction inconsistencies than PERCIST but both benefit from the EARL harmonization program.

Lasnon C, Quak E, Le Roux PY, Robin P, Hofman MS, Bourhis D, Callahan J, Binns DS, Desmonts C, Salaun PY, Hicks RJ, Aide N.

EJNMMI Phys. 2017 Dec;4(1):17. doi: 10.1186/s40658-017-0185-4. Epub 2017 May 30.

7.

The coccidian parasites Toxoplasma and Neospora dysregulate mammalian lipid droplet biogenesis.

Hu X, Binns D, Reese ML.

J Biol Chem. 2017 Jun 30;292(26):11009-11020. doi: 10.1074/jbc.M116.768176. Epub 2017 May 9.

8.

β -[<sup>18</sup>F]Fluoro Azomycin Arabinoside (β -[<sup>18</sup>F]FAZA): Synthesis, Radiofluorination and Preliminary PET Imaging of Murine A431 Tumors.

Kumar P, Roselt P, Reischl G, Cullinane C, Beiki D, Ehrlichmann W, Binns D, Naimi E, Yang J, Hicks R, Machulla HJ, Wiebe LI.

Curr Radiopharm. 2017;10(2):93-101. doi: 10.2174/1874471010666170313120540.

PMID:
28294075
9.

Does PET SUV Harmonization Affect PERCIST Response Classification?

Quak E, Le Roux PY, Lasnon C, Robin P, Hofman MS, Bourhis D, Callahan J, Binns DS, Desmonts C, Salaun PY, Hicks RJ, Aide N.

J Nucl Med. 2016 Nov;57(11):1699-1706. Epub 2016 Jun 9.

11.

Quantitative and qualitative analysis of [(18)F]FDG and [(18)F]FAZA positron emission tomography of head and neck cancers and associations with HPV status and treatment outcome.

Graves EE, Hicks RJ, Binns D, Bressel M, Le QT, Peters L, Young RJ, Rischin D.

Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):617-25. doi: 10.1007/s00259-015-3247-7. Epub 2015 Nov 18.

12.

Applying Advanced Imaging Techniques to a Murine Model of Orthotopic Osteosarcoma.

Broadhead ML, Lokmic Z, Tan ML, Stevenson A, Binns DS, Cullinane C, Hicks RJ, Choong PF, Myers DE.

Front Surg. 2015 Aug 3;2:36. doi: 10.3389/fsurg.2015.00036. eCollection 2015.

13.

STatistically Assigned Response Criteria in Solid Tumors (STARCIST).

Bengtsson T, Sanabria-Bohorquez SM, McCarthy TJ, Binns DS, Hicks RJ, de Crespigny AJ.

Cancer Imaging. 2015 Jul 31;15:9. doi: 10.1186/s40644-015-0042-4.

14.

Harmonizing FDG PET quantification while maintaining optimal lesion detection: prospective multicentre validation in 517 oncology patients.

Quak E, Le Roux PY, Hofman MS, Robin P, Bourhis D, Callahan J, Binns D, Desmonts C, Salaun PY, Hicks RJ, Aide N.

Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2072-82. doi: 10.1007/s00259-015-3128-0. Epub 2015 Jul 30.

15.

68Ga-EDTA PET/CT imaging and plasma clearance for glomerular filtration rate quantification: comparison to conventional 51Cr-EDTA.

Hofman M, Binns D, Johnston V, Siva S, Thompson M, Eu P, Collins M, Hicks RJ.

J Nucl Med. 2015 Mar;56(3):405-9. doi: 10.2967/jnumed.114.147843. Epub 2015 Feb 12.

16.

Seipin performs dissectible functions in promoting lipid droplet biogenesis and regulating droplet morphology.

Cartwright BR, Binns DD, Hilton CL, Han S, Gao Q, Goodman JM.

Mol Biol Cell. 2015 Feb 15;26(4):726-39. doi: 10.1091/mbc.E14-08-1303. Epub 2014 Dec 24.

17.

Bifunctional (64)Cu-labelled macrobicyclic cage amine isothiocyanates for immuno-positron emission tomography.

Paterson BM, Buncic G, McInnes LE, Roselt P, Cullinane C, Binns DS, Jeffery CM, Price RI, Hicks RJ, Donnelly PS.

Dalton Trans. 2015 Mar 21;44(11):4901-9. doi: 10.1039/c4dt02983f.

PMID:
25351329
18.

Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer.

Everitt SJ, Ball DL, Hicks RJ, Callahan J, Plumridge N, Collins M, Herschtal A, Binns D, Kron T, Schneider M, MacManus M.

J Nucl Med. 2014 Jul;55(7):1069-74. doi: 10.2967/jnumed.113.131631. Epub 2014 May 15.

19.

Correlation of p16 status, hypoxic imaging using [18F]-misonidazole positron emission tomography and outcome in patients with loco-regionally advanced head and neck cancer.

Trinkaus ME, Hicks RJ, Young RJ, Peters LJ, Solomon B, Bressel M, Corry J, Fisher R, Binns D, McArthur GA, Rischin D.

J Med Imaging Radiat Oncol. 2014 Feb;58(1):89-97. doi: 10.1111/1754-9485.12155.

PMID:
24529061
20.

Absence of a relationship between tumor ¹⁸F-fluorodeoxyglucose standardized uptake value and survival in patients treated with definitive radiotherapy for non-small-cell lung cancer.

Lin MY, Wu M, Brennan S, Campeau MP, Binns DS, MacManus M, Solomon B, Hicks RJ, Fisher RJ, Ball DL.

J Thorac Oncol. 2014 Mar;9(3):377-82. doi: 10.1097/JTO.0000000000000096.

21.

In vivo measurement of hippocampal GABAA/cBZR density with [18F]-flumazenil PET for the study of disease progression in an animal model of temporal lobe epilepsy.

Vivash L, Gregoire MC, Bouilleret V, Berard A, Wimberley C, Binns D, Roselt P, Katsifis A, Myers DE, Hicks RJ, O'Brien TJ, Dedeurwaerdere S.

PLoS One. 2014 Jan 21;9(1):e86722. doi: 10.1371/journal.pone.0086722. eCollection 2014.

22.

InterProScan 5: genome-scale protein function classification.

Jones P, Binns D, Chang HY, Fraser M, Li W, McAnulla C, McWilliam H, Maslen J, Mitchell A, Nuka G, Pesseat S, Quinn AF, Sangrador-Vegas A, Scheremetjew M, Yong SY, Lopez R, Hunter S.

Bioinformatics. 2014 May 1;30(9):1236-40. doi: 10.1093/bioinformatics/btu031. Epub 2014 Jan 21.

23.

Preclinical FLT-PET and FDG-PET imaging of tumor response to the multi-targeted Aurora B kinase inhibitor, TAK-901.

Cullinane C, Waldeck KL, Binns D, Bogatyreva E, Bradley DP, de Jong R, McArthur GA, Hicks RJ.

Nucl Med Biol. 2014 Feb;41(2):148-54. doi: 10.1016/j.nucmedbio.2013.11.001. Epub 2013 Nov 15.

PMID:
24332383
24.

PET imaging of tumours with a 64Cu labeled macrobicyclic cage amine ligand tethered to Tyr3-octreotate.

Paterson BM, Roselt P, Denoyer D, Cullinane C, Binns D, Noonan W, Jeffery CM, Price RI, White JM, Hicks RJ, Donnelly PS.

Dalton Trans. 2014 Jan 21;43(3):1386-96. doi: 10.1039/c3dt52647j. Epub 2013 Nov 7.

PMID:
24202174
25.

High-resolution imaging of pulmonary ventilation and perfusion with 68Ga-VQ respiratory gated (4-D) PET/CT.

Callahan J, Hofman MS, Siva S, Kron T, Schneider ME, Binns D, Eu P, Hicks RJ.

Eur J Nucl Med Mol Imaging. 2014 Feb;41(2):343-9. doi: 10.1007/s00259-013-2607-4. Epub 2013 Nov 6.

PMID:
24196920
26.

Diagnostic imaging agents for Alzheimer's disease: copper radiopharmaceuticals that target Aβ plaques.

Hickey JL, Lim S, Hayne DJ, Paterson BM, White JM, Villemagne VL, Roselt P, Binns D, Cullinane C, Jeffery CM, Price RI, Barnham KJ, Donnelly PS.

J Am Chem Soc. 2013 Oct 30;135(43):16120-32. doi: 10.1021/ja4057807. Epub 2013 Oct 16.

PMID:
24070589
27.

Imaging of hypoxia with 18F-FAZA PET in patients with locally advanced non-small cell lung cancer treated with definitive chemoradiotherapy.

Trinkaus ME, Blum R, Rischin D, Callahan J, Bressel M, Segard T, Roselt P, Eu P, Binns D, MacManus MP, Ball D, Hicks RJ.

J Med Imaging Radiat Oncol. 2013 Aug;57(4):475-81. doi: 10.1111/1754-9485.12086. Epub 2013 Jun 14.

PMID:
23870348
28.

18F-flumazenil: a γ-aminobutyric acid A-specific PET radiotracer for the localization of drug-resistant temporal lobe epilepsy.

Vivash L, Gregoire MC, Lau EW, Ware RE, Binns D, Roselt P, Bouilleret V, Myers DE, Cook MJ, Hicks RJ, O'Brien TJ.

J Nucl Med. 2013 Aug;54(8):1270-7. doi: 10.2967/jnumed.112.107359. Epub 2013 Jul 15.

29.

Validation of a 4D-PET maximum intensity projection for delineation of an internal target volume.

Callahan J, Kron T, Schneider-Kolsky M, Dunn L, Thompson M, Siva S, Aarons Y, Binns D, Hicks RJ.

Int J Radiat Oncol Biol Phys. 2013 Jul 15;86(4):749-54. doi: 10.1016/j.ijrobp.2013.02.030. Epub 2013 Apr 16.

PMID:
23601897
30.

The use of fused PET/CT images for patient selection and radical radiotherapy target volume definition in patients with non-small cell lung cancer: results of a prospective study with mature survival data.

Mac Manus MP, Everitt S, Bayne M, Ball D, Plumridge N, Binns D, Herschtal A, Cruickshank D, Bressel M, Hicks RJ.

Radiother Oncol. 2013 Mar;106(3):292-8. doi: 10.1016/j.radonc.2012.12.018. Epub 2013 Mar 28.

PMID:
23541364
31.

The impact of time between staging PET/CT and definitive chemo-radiation on target volumes and survival in patients with non-small cell lung cancer.

Everitt S, Plumridge N, Herschtal A, Bressel M, Ball D, Callahan J, Kron T, Schneider-Kolsky M, Binns D, Hicks RJ, Mac Manus M.

Radiother Oncol. 2013 Mar;106(3):288-91. doi: 10.1016/j.radonc.2013.02.010. Epub 2013 Mar 13.

32.

Sex and SUVmax: sex-dependent prognostication in early non-small cell lung cancer.

Wainer Z, Daniels MG, Callahan J, Binns D, Hicks RJ, Antippa P, Russell PA, Alam NZ, Conron M, Solomon B, Wright GM.

J Nucl Med. 2012 Nov;53(11):1676-85. doi: 10.2967/jnumed.112.105197. Epub 2012 Sep 14.

33.

Scatter limitation to correct for arm movement in PET/CT.

Callahan J, Binns D, Deller T, Hicks RJ.

Clin Nucl Med. 2012 Aug;37(8):786-7. doi: 10.1097/RLU.0b013e3182531cdf.

PMID:
22785512
34.

Hypometabolism precedes limbic atrophy and spontaneous recurrent seizures in a rat model of TLE.

Jupp B, Williams J, Binns D, Hicks RJ, Cardamone L, Jones N, Rees S, O'Brien TJ.

Epilepsia. 2012 Jul;53(7):1233-44. doi: 10.1111/j.1528-1167.2012.03525.x. Epub 2012 Jun 12.

35.

Effect of PET/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data.

Gregory DL, Hicks RJ, Hogg A, Binns DS, Shum PL, Milner A, Link E, Ball DL, Mac Manus MP.

J Nucl Med. 2012 Jul;53(7):1007-15. doi: 10.2967/jnumed.111.099713. Epub 2012 Jun 7.

36.

InterPro in 2011: new developments in the family and domain prediction database.

Hunter S, Jones P, Mitchell A, Apweiler R, Attwood TK, Bateman A, Bernard T, Binns D, Bork P, Burge S, de Castro E, Coggill P, Corbett M, Das U, Daugherty L, Duquenne L, Finn RD, Fraser M, Gough J, Haft D, Hulo N, Kahn D, Kelly E, Letunic I, Lonsdale D, Lopez R, Madera M, Maslen J, McAnulla C, McDowall J, McMenamin C, Mi H, Mutowo-Muellenet P, Mulder N, Natale D, Orengo C, Pesseat S, Punta M, Quinn AF, Rivoire C, Sangrador-Vegas A, Selengut JD, Sigrist CJ, Scheremetjew M, Tate J, Thimmajanarthanan M, Thomas PD, Wu CH, Yeats C, Yong SY.

Nucleic Acids Res. 2012 Jan;40(Database issue):D306-12. doi: 10.1093/nar/gkr948. Epub 2011 Nov 16.

37.

Motion effects on SUV and lesion volume in 3D and 4D PET scanning.

Callahan J, Binns D, Dunn L, Kron T.

Australas Phys Eng Sci Med. 2011 Dec;34(4):489-95. doi: 10.1007/s13246-011-0109-x. Epub 2011 Nov 12.

PMID:
22081269
38.

The InterPro BioMart: federated query and web service access to the InterPro Resource.

Jones P, Binns D, McMenamin C, McAnulla C, Hunter S.

Database (Oxford). 2011 Jul 23;2011:bar033. doi: 10.1093/database/bar033. Print 2011.

39.

Differential (18)F-FDG and 3'-deoxy-3'-(18)F-fluorothymidine PET responses to pharmacologic inhibition of the c-MET receptor in preclinical tumor models.

Cullinane C, Dorow DS, Jackson S, Solomon B, Bogatyreva E, Binns D, Young R, Arango ME, Christensen JG, McArthur GA, Hicks RJ.

J Nucl Med. 2011 Aug;52(8):1261-7. doi: 10.2967/jnumed.110.086967. Epub 2011 Jul 15.

40.

The yeast lipin orthologue Pah1p is important for biogenesis of lipid droplets.

Adeyo O, Horn PJ, Lee S, Binns DD, Chandrahas A, Chapman KD, Goodman JM.

J Cell Biol. 2011 Mar 21;192(6):1043-55. doi: 10.1083/jcb.201010111.

41.

Automatic tumour volume delineation in respiratory-gated PET images.

Gubbi J, Kanakatte A, Tomas K, Binns D, Srinivasan B, Mani N, Palaniswami M.

J Med Imaging Radiat Oncol. 2011 Feb;55(1):65-76. doi: 10.1111/j.1754-9485.2010.02231.x.

PMID:
21382191
42.

Compliance with PET acquisition protocols for therapeutic monitoring of erlotinib therapy in an international trial for patients with non-small cell lung cancer.

Binns DS, Pirzkall A, Yu W, Callahan J, Mileshkin L, Conti P, Scott AM, Macfarlane D, Fine BM, Hicks RJ; OSI3926g Study Team.

Eur J Nucl Med Mol Imaging. 2011 Apr;38(4):642-50. doi: 10.1007/s00259-010-1665-0. Epub 2011 Jan 5.

PMID:
21207024
43.

The proline/arginine-rich domain is a major determinant of dynamin self-activation.

Barylko B, Wang L, Binns DD, Ross JA, Tassin TC, Collins KA, Jameson DM, Albanesi JP.

Biochemistry. 2010 Dec 21;49(50):10592-4. doi: 10.1021/bi101343p. Epub 2010 Nov 23.

44.

Seipin is a discrete homooligomer.

Binns D, Lee S, Hilton CL, Jiang QX, Goodman JM.

Biochemistry. 2010 Dec 21;49(50):10747-55. doi: 10.1021/bi1013003. Epub 2010 Nov 18.

45.

Progressive metabolic and structural cerebral perturbations after traumatic brain injury: an in vivo imaging study in the rat.

Liu YR, Cardamone L, Hogan RE, Gregoire MC, Williams JP, Hicks RJ, Binns D, Koe A, Jones NC, Myers DE, O'Brien TJ, Bouilleret V.

J Nucl Med. 2010 Nov;51(11):1788-95. doi: 10.2967/jnumed.110.078626.

46.

Association between pulmonary uptake of fluorodeoxyglucose detected by positron emission tomography scanning after radiation therapy for non-small-cell lung cancer and radiation pneumonitis.

Mac Manus MP, Ding Z, Hogg A, Herschtal A, Binns D, Ball DL, Hicks RJ.

Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1365-71. doi: 10.1016/j.ijrobp.2010.04.021. Epub 2010 Aug 2.

PMID:
20675076
47.

High rates of tumor growth and disease progression detected on serial pretreatment fluorodeoxyglucose-positron emission tomography/computed tomography scans in radical radiotherapy candidates with nonsmall cell lung cancer.

Everitt S, Herschtal A, Callahan J, Plumridge N, Ball D, Kron T, Schneider-Kolsky M, Binns D, Hicks RJ, MacManus M.

Cancer. 2010 Nov 1;116(21):5030-7. doi: 10.1002/cncr.25392.

48.

Distribution of proliferating bone marrow in adult cancer patients determined using FLT-PET imaging.

Hayman JA, Callahan JW, Herschtal A, Everitt S, Binns DS, Hicks RJ, Mac Manus M.

Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):847-52. doi: 10.1016/j.ijrobp.2009.11.040. Epub 2010 May 14.

PMID:
20472367
49.

QuickGO: a user tutorial for the web-based Gene Ontology browser.

Huntley RP, Binns D, Dimmer E, Barrell D, O'Donovan C, Apweiler R.

Database (Oxford). 2009;2009:bap010. Epub 2009 Sep 29.

50.

QuickGO: a web-based tool for Gene Ontology searching.

Binns D, Dimmer E, Huntley R, Barrell D, O'Donovan C, Apweiler R.

Bioinformatics. 2009 Nov 15;25(22):3045-6. doi: 10.1093/bioinformatics/btp536. Epub 2009 Sep 10.

Supplemental Content

Support Center